Evaluation of the Possibility of Correction of Doxorubicin-Induced Chronic Heart Failure in the Experiment with 3-Hydroxypyridine Acetylcysteinate and 3-Hydroxypyridine Succinate
- 作者: Zamotaeva M.1, Inchina V.1, Konorev V.1, Kuznetsov Y.2, Kuz’michev N.1
-
隶属关系:
- N. P. Ogarev Mordovian National Research State University
- N. M. Emanuel Institute of Biochemical Physics
- 期: 卷 165, 编号 3 (2018)
- 页面: 344-346
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/240286
- DOI: https://doi.org/10.1007/s10517-018-4166-y
- ID: 240286
如何引用文章
详细
The possibility of correction of morphological changes in the myocardium and biochemical parameters of the blood with 3-hydroxypyridine acetylcysteinate in a dose of 25 mg/kg was studied in the model of doxorubicin-induced chronic heart failure in rats. It was found that 3-hydroxypyridine acetylcysteinate in a dose of 25 mg/kg produced less pronounced cardio-protective effect in experimental chronic heart failure than 3-hydroxypyridine succinate.
作者简介
M. Zamotaeva
N. P. Ogarev Mordovian National Research State University
Email: konarewv@rambler.ru
俄罗斯联邦, Saransk, Republic of Mordovia
V. Inchina
N. P. Ogarev Mordovian National Research State University
Email: konarewv@rambler.ru
俄罗斯联邦, Saransk, Republic of Mordovia
V. Konorev
N. P. Ogarev Mordovian National Research State University
编辑信件的主要联系方式.
Email: konarewv@rambler.ru
俄罗斯联邦, Saransk, Republic of Mordovia
Yu. Kuznetsov
N. M. Emanuel Institute of Biochemical Physics
Email: konarewv@rambler.ru
俄罗斯联邦, Moscow
N. Kuz’michev
N. P. Ogarev Mordovian National Research State University
Email: konarewv@rambler.ru
俄罗斯联邦, Saransk, Republic of Mordovia
![](/img/style/loading.gif)